2019 annual financial data
Puma Biotechnology 2019 Operating margin
Direct answer
Operating margin was -27.77%.
Operating income was -75,595,000 USD and net income was -75,595,000 USD.
Operating cash flow was 22,376,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 272,260,000 USD
- Operating income
- -75,595,000 USD
- Net income
- -75,595,000 USD
- Operating cash flow
- 22,376,000 USD